Publications by authors named "M Harishankar"

Claim this Profile
C
Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.
Anjali P Patni, M K Harishankar, Joel P Joseph, Bhuvanadas Sreeshma, Rama Jayaraj

Cell Oncol (Dordr)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Applications of Induced Pluripotent Stem Cells - Stato Attuale.
Chavali Kavyasudha, Dannie Macrin, K N ArulJothi, Joel P Joseph, M K Harishankar

Adv Exp Med Biol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1, 25-dihydroxyvitamin D downregulates cytotoxic effector response in pulmonary tuberculosis.
K Afsal, P Selvaraj, M Harishankar

Int Immunopharmacol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Genetic Polymorphism Towards Pulmonary Tuberculosis Susceptibility.
Murugesan Harishankar, Paramasivam Selvaraj, Ramalingam Bethunaickan

Front Med (Lausanne)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC.
Joel P Joseph, M K Harishankar, Aruthra Arumugam Pillai, Arikketh Devi

Oral Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis